I am driven by supporting healthcare clients achieve growth and innovation, benefiting patients and their families.
Josh provides mergers and acquisitions (M&A) advisory to healthcare companies across various sectors, including post-acute, hospital outsourcing, consumer health and lab services. He is focused on buy-side and sell-side transactions for private equity firms and public and privately held companies located in the United States, Europe and Asia.
Josh works closely with clients to understand their business and goals, allowing him to apply deep healthcare and investment banking expertise to drive successful outcomes.
Prior to Lincoln, Joshua held roles in the M&A and restructuring practices at Hammond Hanlon Camp and Riveron. Josh began his career at Cantor Fitzgerald as an analyst in its corporate finance management program.
Josh earned a Bachelor of Science from Fordham University.
Lincoln International advised PhyMed Healthcare Group has been sold in a series of transactions to strategic acquirers
Lincoln International has advised Amazing Care, a portfolio company of 3 Rivers Capital, on recapitalization by Bow River Capital
Lincoln International advised Panorama Point Partners, Dixon Midland and ORIX on the sale of Midwest Medical Transport to Harbour Point Capital
Related Perspectives in Healthcare
What’s Old is New Again: Value-Based Care Delivery in the Home
In 1930, physicians visiting patients in their residences represented 40 percent of all encounters. 20 years later this figure had fallen dramatically to just one visit in 10. By the… Read More
Meet our Senior Team in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt